Beta-Defensin vs Zinc Injection
A side-by-side research comparison of Beta-Defensin and Zinc Injection across mechanism, dosing, half-life, benefits, side effects and research status.
Comparison table
| Attribute | Beta-Defensin | Zinc Injection |
|---|---|---|
| Full name | Human Beta-Defensin Peptides | Zinc Sulfate Injectable |
| Category | Immune Support | Immune Support |
| Status | Research compound | Compounded supplement |
| Mechanism | Form pores in microbial membranes causing lysis, recruit immune cells via CCR6 receptor chemotaxis, and bridge innate and adaptive immunity by activating dendritic cells. | Essential cofactor for 300+ enzymes. Critical for T-cell maturation, NK cell activity, zinc finger protein transcription factors, testosterone synthesis, and wound healing metalloproteinases. |
| Molecular weight | 4000-5000 Da | 287.56 Da |
| Half-life | ~2-4 hours | Stored in tissues (~2-3 week turnover) |
| Bioavailability | Primarily local/mucosal activity | ~100% injectable |
| Typical dose | 50-200 mcg | 5-10 mg elemental zinc |
| Frequency | Daily or as needed | 1-2x per week |
| Route | Topical or subcutaneous | Intramuscular or IV injection |
Beta-Defensin reported benefits
- Broad antimicrobial activity
- Immune cell recruitment
- Wound healing support
- Biofilm disruption
Zinc Injection reported benefits
- Immune system support
- Testosterone production
- Wound healing
- Thyroid function
- Antioxidant support
Related comparisons
Research and educational reference only. Not medical advice.